Nac1 Coordinates a Sub-network of Pluripotency Factors to Regulate Embryonic Stem Cell Differentiation  by Malleshaiah, Mohan et al.
ArticleNac1 Coordinates a Sub-network of Pluripotency
Factors to Regulate Embryonic Stem Cell
DifferentiationGraphical AbstractHighlightsd A sub-network of Nac1, Oct4, Tcf3, and Sox2 promotes ESC
differentiation
d Nac1 controls the sub-network to promote ME and repress
NE fate selection
d Nac1 and Oct4 favor the ME, and Tcf3 and Sox2 favor the NE,
fate choice
d The four TF levels are constrained within quantitative
windows in ME and NE cellsMalleshaiah et al., 2016, Cell Reports 14, 1181–1194
February 9, 2016 ª2016 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.12.101Authors
Mohan Malleshaiah, Megha Padi,
Pau Rue´, John Quackenbush,
Alfonso Martinez-Arias,
Jeremy Gunawardena
Correspondence
mohan_malleshaiah@hms.harvard.edu
(M.M.),
jeremy_gunawardena@hms.harvard.edu
(J.G.)
In Brief
Progenitor cells choose a distinct fate
between alternative choices during
development. Malleshaiah et al. now
show that pluripotent mouse embryonic
stem cells decide between
mesendodermal and neuroectodermal
fates through a sub-network of
pluripotency transcription factors, Oct4,
Sox2, Tcf3, and Nac1, that is coordinated
by Nac1 and constrains protein levels
within distinct ranges in each fate.
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Pluripotent cells give rise to distinct cell types dur-
ing development and are regulated by often self-re-
inforcing molecular networks. How such networks
allow cells to differentiate is less well understood.
Here, we use integrative methods to show that
external signals induce reorganization of the mouse
embryonic stem cell pluripotency network and that
a sub-network of four factors, Nac1, Oct4, Tcf3,
and Sox2, regulates their differentiation into the
alternative mesendodermal and neuroectodermal
fates. In the mesendodermal fate, Nac1 and Oct4
were constrained within quantitative windows,
whereas Sox2 and Tcf3 were repressed. In contrast,
in the neuroectodermal fate, Sox2 and Tcf3 were
constrained while Nac1 and Oct4 were repressed.
In addition, we show that Nac1 coordinates differ-
entiation by activating Oct4 and inhibiting both
Sox2 and Tcf3. Reorganization of progenitor cell
networks around shared factors might be a com-
mon differentiation strategy and our integrative
approach provides a general methodology for delin-
eating such networks.INTRODUCTION
Stem cells give rise to multiple cell types of an organism through
progressive differentiation. While successive new fates are
being specified, alternative fates are restricted to create distinct
cell lineages (Graf and Enver, 2009; Waddington, 1957). Cell
fate-specifying information, in the form of spatial cues or inter-
cellular signals, is processed through molecular networks
whose causal regulations and dynamics ultimately define the
final cellular outcome (Davidson, 2006). Understanding how
such a network changes during cell fate choice is thus
crucial to understanding development. Embryonic stem cells
(ESCs), which are both pluripotent and self-renewing (EvansCell Rand Kaufman, 1981; Martin, 1981; Nishikawa et al., 2007), repre-
sent a good model system for addressing this problem.
Mouse ESCs are regulated by an ensemble of transcription
factors (TFs), including Pou5f1 (Oct4), Nanog, Sox2, Rex1,
Nacc1 (Nac1), Klf4, cMyc, and others (Figure S1A), which pro-
mote pluripotency by activating their own expression, and that
of other pluripotency genes, and by suppressing genes required
for differentiation (Cole and Young, 2008; Ng and Surani, 2011;
Niwa, 2007; Silva and Smith, 2008). The key stem cell factor
Nanog plays a central role in establishing the self-reinforcing
pluripotency network through nested positive feedback and
feedforward regulations (Cole and Young, 2008; MacArthur
et al., 2012). However, how the self-reinforcing regulations of
the pluripotency network change as ESCs differentiate into alter-
native cell fates is not well understood.
Here, we used an integrative and quantitative approach to
analyze how these regulations change as mouse ESCs exit plu-
ripotency and choose between the alternative mesendodermal
(ME) and neuroectodermal (NE) cell fates (Figure 1A) that act
as precursors for germ layer specification during development
(Gadue et al., 2005). We found that, during differentiation, the
pluripotency network reorganizes around four key TFs—Nac1,
Oct4, Tcf3, and Sox2—and that Nac1, a BEN and BTB (POZ)
domain-containing protein (Mackler et al., 2000), plays a coordi-
nating role. Our findings suggest that pluripotency is a mutually
balanced state among the differentiation-promoting factors,
which then resolves during differentiation. Similar mechanisms
may underlie the maintenance and differentiation of other pro-
genitor and stem cells.RESULTS
Dynamic Changes in TF Levels as ESCs Exit
Pluripotency
We studied the dynamic changes to the pluripotency network
during mouse ESC differentiation into the ME and NE fates by
systematically quantifying the TFs that regulate the ES state
(Figures 1 and S1). In total, we measured thirteen TFs that
included nine important members of the extended pluripotency
network (Oct4, Sox2, Nanog, Klf4, cMyc, Nac1, Dax1, Rex1,eports 14, 1181–1194, February 9, 2016 ª2016 The Authors 1181
Figure 1. Differentiation-Induced Changes
in the Levels of Pluripotency Factors
(A) Embryonic stem cells (ESCs) exit pluripotency
to choose between mesendodermal (ME) and
neuroectodermal (NE) germ layer precursor fates,
guided by Wnt and Activin and retinoic acid,
respectively (Gadue et al., 2006; Thomson et al.,
2011; Ying et al., 2003).
(B and C) The proportions of cells in the pluripotent
(ES), ME, NE, and other undetermined states, at the
indicated time points during ESC (Sox1-GFP cell
line) differentiation toward the ME (B) and NE (C)
fates, are shown.
(D and E) Changes in the levels of indicated plu-
ripotency factors during ME (D) and NE (E) differ-
entiations. For each protein, median value (from
single-cell data) at the indicated time point was
normalized to its maximum from the respective
differentiation condition.
See also Figure S1 and the Supplemental Experi-
mental Procedures.and Zfp281) (Kim et al., 2008;Wang et al., 2006) and others (Tcf3,
Klf5, p53, and Tbx3), which are thought to have various roles in
regulating pluripotency (Cole et al., 2008; Ema et al., 2008; Han
et al., 2010; Neveu et al., 2010). This set of TFs included the
stem cell trinity of Oct4, Sox2, and Nanog (Silva and Smith,
2008); the Yamanaka reprogramming factors Oct4, Sox2, Klf4,
and cMyc (Takahashi and Yamanaka, 2006); and the Wnt-
responsive Tcf3, which modulates the balance between pluripo-
tency and differentiation (Atlasi et al., 2013; Cole et al., 2008;
Wray et al., 2011).
ESCs can be differentiated in vitro into either the ME or NE
fate: Chiron (CHIR99021, a Wnt agonist that inhibits glycogen
synthase kinase 3b) plus Activin-A together promote the ME
fate, while retinoic acid promotes the NE fate (Figure 1A; Gadue
et al., 2006; Thomson et al., 2011; Ying et al., 2003). We em-
ployed these signals to induce the ME and NE fates from
ESCs, and we primarily focused on analyzing the reorganization
of the pluripotency transcriptional network during differentiation
(Figures 1 and S1; Supplemental Experimental Procedures). To
examine the temporal response to the signals, we followed cell
populations for time periods of 0, 24, 32, 40, ..., and 120 hr of
ME and NE differentiation (Figures 1B and 1C). A limited mixture
of ME and NE fates was observed under the pluripotency condi-1182 Cell Reports 14, 1181–1194, February 9, 2016 ª2016 The Authorstion (0 hr), but these populations quickly
diverged and, by 40 hr, differentiation
was specific and exclusive. By 72–80 hr,
a maximal proportion of cells expressed
the fate-specific T or Sox1 markers under
the respective differentiation condition.
We noticed a higher proportion of un-
differentiated cells under ME than NE
possibly due to Chiron, which is also
known to promote pluripotency (Ying
et al., 2008).
We then measured the protein levels for
all 13 TFs in a 96-hr time course for each
differentiation condition using quantitativeimmunofluorescence in wild-type ESCs (Figures S1F and S1G;
Supplemental Experimental Procedures). Different cell popula-
tions were used for each immunostaining to measure up to three
TFs and nuclear DNA. Oct4 was measured across all immunos-
tainings as a consistency check. At a given time point and
condition, protein measurements were fairly consistent across
immunostainings (Figure S1H: representative single-cell distri-
butions of Oct4). ME and NE differentiation signals regulated
the TF protein levels differently (Figures S1I and S1J: representa-
tive single-cell distributions of Oct4 across all time points).
The majority of the median TF protein levels decreased over
time (Figures 1D and 1E), with the decrease being more promi-
nent for NE than for ME, particularly for the trinity of Nanog,
Oct4, and Sox2. In contrast, Tcf3 decreased more rapidly for
ME than for NE, as expected since the ME condition is induced
by Chiron, a Wnt agonist, and Wnt signaling inhibits Tcf3 (Atlasi
et al., 2013; Wray et al., 2011). Klf5, p53, and Tbx3 showed
similar dynamics under both ME and NE conditions, and
Zfp281, cMyc, and Dax1 showed the least overall changes.
These temporal changes are largely consistent with previous ob-
servations involving both directed and undirected differentiation
experiments (Lu et al., 2009;MacArthur et al., 2012; Pereira et al.,
2006; Thomson et al., 2011). Our results captured the varying
Figure 2. Identification of Potential Differen-
tiation Regulatory TFs by Computational
Analysis
(A–D) Principal-component analysis (PCA) using the
median values of nine pluripotency factors, Oct4,
Nanog, Sox2, Klf4, Rex1, Nac1, Zfp281, Dax1, and
cMyc (A and B), and these nine plus Tcf3 (C and D)
for the ME (red) and NE (blue) conditions is shown.
(E and F) PCA with all 13 measured TFs. Principal
component (PC) projections are shown as PC1
versus PC2 and PC2 versus PC3 plots.
(G and H) Dynamic Bayesian network (DBN) anal-
ysis using median values of the ten TFs (above nine
plus Tcf3) for ME (G) and NE (H) differentiation. The
nodes are colored using a scale based on domi-
nance scores that have been max-normalized for
each network separately as follows: white (%0.5),
red gradient (0.5–1), and red (1). The edges are
colored using a scale based on their posterior
probability predictions with a threshold of 0.25 as
follows: off-white (0.25), gray scale (0.25–0.5), and
black (>0.5). The extent of connectivity measured
by dominance scores indicated the top four factors
in the ME (G) and NE (H) networks. DBNs are drawn
using Cytoscape.
See also Figure S2 and Experimental Procedures.dynamics of the TFs as ESCs exit pluripotency and transit
toward the ME or NE fate. These dynamic changes in TFs coin-
cide with the onset of differentiation marked by T or Sox1
expression (Figures 1B and 1C). To understand how these dy-
namic changes in TF levels influence their causal regulations
and the cell fate transition and to identify the key regulators
behind these changes, we turned to computational analysis.Cell Reports 14, 1181–1194,Computational Analysis Reveals
Potential Pluripotency Factors
Involved in Differentiation
We employed principal-component anal-
ysis (PCA) to extract the main features
of the differentiation dynamics. PCA de-
termines a sequence of orthogonal vec-
tors that best captures the shape of the
variance in a dataset (Jolliffe, 2002). The
contribution of individual factors toward
the collective behavior of all factors within
a network can be assessed using PCA.
We represented the median levels of
each TF as a multi-dimensional vector,
at all 13 time points (samples every 8 hr
from 0 to 96 hr) for both ME and NE
conditions.
We first analyzed the extended plu-
ripotency network with the following nine
TFs: Oct4, Sox2, Nanog, Klf4, cMyc,
Rex1, Nac1, Dax1, and Zfp281 (Kim
et al., 2008; Wang et al., 2006). The first
three principal components (PCs)
captured over 95% of the variance in the
data (Figures 2A and 2B). PC1, which ac-counts for 80% of the variance, captured the change in time;
PC2 partially captured the difference between differentiation
conditions; and PC3 captured the changes within each condi-
tion. Although the two fates had different trajectories, they
were indistinguishable along PC2 at several ME and NE time
points (Figures 2A and 2B). This was in contrast to the mutually
exclusive ME or NE choice observed (Figures 1B and 1C),February 9, 2016 ª2016 The Authors 1183
suggesting that the nine factors were not sufficient to fully distin-
guish the two fate choices.
A second PCA analysis, which included each of the addi-
tional TFs measured as the tenth TF, revealed a distinct role
for Tcf3. While there were no changes with Klf5, p53, or
Tbx3, inclusion of Tcf3 surprisingly clearly separated the two
differentiation trajectories (Figures 2C, 2D, and S2A–S2C).
Tcf3 contributed significantly to PC2 (Figure S2M), suggesting
that it played an important role in distinguishing the ME and
NE fates. To further verify the role of each TF, we excluded
them one at a time and repeated the analysis. While exclusion
of Nac1, Oct4, or Sox2 had severe effects on the trajectory
separation (Figures S2D–S2F), exclusion of the other TFs on
the other hand had less effect (Figures S2G–S2L). In agreement
with their role, the four TFs Nac1, Oct4, Sox2, and Tcf3 were
the dominant contributors to PC coefficients (Figure S2M).
Furthermore, PCA on all 13 proteins gave no further improve-
ment (Figures 2E and 2F).
As a complementary approach to PCA, we used dynamic
Bayesian networks (DBNs). Bayesian networks have been
used widely to infer causal relationships and to identify key reg-
ulators from complex biological data (Friedman et al., 2000;
Pe’er, 2005; Figure S2N). Non-homogeneous DBNs allow
different model structures during each segment of a time course,
making it particularly applicable to processes like stem cell dif-
ferentiation in which the underlying causal network is not neces-
sarily static (Dondelinger et al., 2013). We assumed the initial
DBN network to be random, and we incorporated in it the
previously known ME-promoting function of Oct4 through
Sox2 regulation (Thomson et al., 2011) and the general differen-
tiation-promoting function of Tcf3 through Nanog, Oct4, and
Rex1 regulations (Cole et al., 2008; Pereira et al., 2006; Wray
et al., 2011; Supplemental Experimental Procedures).
We used aMarkov chainMonte Carlo algorithm to find optimal
and robust non-homogeneous DBNs with the median values of
the ten TFs considered above (Oct4, Sox2, Nanog, Klf4, cMyc,
Rex1, Nac1, Dax1, Zfp281, and Tcf3), at all 13 time points, for
ME and NE conditions separately (Figures 2G and 2H). The in-
ferred ME and NE networks were distinct from each other, sug-
gesting that the causal network of pluripotency may undergo
major reorganization during differentiation. Change-point anal-
ysis further suggested that the initial network changes the
most within the first 32 hr of differentiation (Figures S2O and
S2P), with no significant changes after 72 hr. These dynamic
changes to the pluripotency network precede the emergence
of the ME and NE fate markers (Figures 1B and 1C). To identify
the dominant regulators in the predicted causal networks, we as-
signed a score for each protein to estimate the degree of its
connectedness (Supplemental Experimental Procedures).
These dominance scores indicated the most important proteins
that determine the inferredME andNE networks as follows: Tcf3,
Nac1, Oct4, and Klf4 for ME; and Sox2, Tcf3, Nanog, and Klf4
for NE (Figures 2G and 2H).
Given that PCA analysis also had highlighted the potential dif-
ferentiation roles for Sox2, Oct4, Nac1, and Tcf3, we pursued the
hypothesis that these proteins, plus Nanog and Klf4, may play a
key role in regulating theME and NE fate choices. To explore this
we turned to quantitative single-cell experiments.1184 Cell Reports 14, 1181–1194, February 9, 2016 ª2016 The AuthoNac1 and Oct4 Promote the ME Fate and Tcf3 and Sox2
Promote the NE Fate
We first examined the expression ranges and the correlations
between protein levels of the above six TFs in pluripotent cells
maintained in the presence of leukemia inhibitory factor (LIF)
and BMP4 (ES condition). Protein levels were measured in single
cells using quantitative immunofluorescence. Max-normalized
protein levels indicated that all factors, except Tcf3, occupied
all three ranges of expression, low, medium, and high (Figures
S3A–S3F). In addition, their expression levels correlated highly
with each other (Figure S3G), consistent with the self-reinforcing
nature of the pluripotency network (Cole and Young, 2008;
MacArthur et al., 2012; Niwa, 2007; Silva and Smith, 2008).
Tcf3 levels, on the other hand, remained low in comparison to
their maximum under the NE condition and poorly correlated
with Nac1, Oct4, and Nanog.
Next, to delineate the quantitative patterns of these six pro-
teins, we measured their levels in single ME and NE cells at
72 hr into differentiation. Although the measurements at earlier
time points might be informative, especially to address hetero-
geneity in response, at 72 hr, differentiation has just reached its
maximal level with reduced variability, allowing us to collect
data from a statistically significant number of ME- or NE-posi-
tive cells (Figures 1 and S1). This time point also was well
suited for assessing the impact of the perturbation experiments
reported below. The cell fate marker signal was normalized
across both ME and NE conditions to the maximum of its sin-
gle-cell level in the respective condition: ME for T and NE for
Sox1. Similarly, each TF level, except that of Tcf3, was normal-
ized across both conditions to its single-cell maximum under
the ES condition. Since Tcf3 was highest under NE, it was
normalized to its maximum under the NE condition (Supple-
mental Experimental Procedures). Each normalized protein
value was plotted against the normalized ME or NE fate marker
(Figures 3 and S3J–S3M). As observed earlier (Figures 1B and
1C), the differentiation was mutually exclusive, with no NE fate
visible under ME and no NE fate visible under ME (Figures S3H
and S3I).
Normalized TF levels were divided into three ranges as fol-
lows: low (0–0.2; 0–0.3 for Tcf3), medium (0.2–0.7), and high
(0.71.0); and fate markers were divided into low (0–0.2) and
high (0.2–1.0). Two characteristic shapes are observed from
the single-cell plots of TF level versus fate marker (Figures 3
and S3J–S3M) as follows: an L shape, indicating mutual exclu-
sivity between ES (undifferentiated cells below the fate marker
threshold) and ME (for Sox2, Tcf3, Nanog, and Klf4) or NE
(for Nac1, Oct4, and Nanog) cells; and a V shape, in which the
protein level can be high when the fate marker is low, but is
restricted to be medium if the fate marker is high (for Nac1 and
Oct4 in ME and for Sox2 in NE cells). Tcf3 is somewhat similar;
it exhibits a truncated L shape under ME, presumably due to
its inhibition by Chiron, and a broader cone-like shape under
NE, in which its level is medium or high when the fate marker
is high.
These results suggested that the central pluripotency factors,
such as Nanog and Klf4, are not required for ESC differentiation
and were generally repressed (Figures S3J–S3M). The remaining
four factors, on the other hand, were differentially regulatedrs
Figure 3. Differential Regulation of Potential TFs in the ME and NE Cells
(A–H) Representative qualitative images (left) and quantitative single-cell measurements (right) for Nac1 (A and B), Oct4 (C and D), Sox2 (E and F), and Tcf3
(G andH) inME andNE differentiation conditions. T and the indicated proteins were quantified by immunofluorescence in Sox1-GFP ESC line. Mean fluorescence
intensities of each protein from single cells, normalized as explained in the text, are plotted against the T (ME marker) and Sox1-GFP (NE marker) levels, also
normalized, in each panel. Cells were fixed, stained, and measurements were done at 72 hr of differentiation. Dashed lines indicate the division of TF levels into
low, medium, and high and fate markers into low and high ranges, as explained in the text. Scale bars represent 35 mm.
See also Figures S3 and S4.(Figure 3). Nac1 and Oct4 were constrained within a quantitative
window, neither too high nor too low, in ME cells, but were
repressed in NE cells (above the fate marker threshold in Figures
3A–3D). Similarly, Sox2 was constrained to intermediate levels
and Tcf3 to intermediate-to-high levels in NE cells, but they
were repressed in ME cells (Figures 3E–3H). Additionally, weCell Rtested four other TFs, Esrrb, Sall4, Smad1, and E2f1, for their
quantitative levels in ME and NE cells. These TFs are known to
promote pluripotency (Chen et al., 2008; Dunn et al., 2014) but
were not part of our original dataset. We found that, in a way
similar to Klf4 and Nanog, the levels of these factors are equally
downregulated in both ME and NE cells (Figure S4). Together,eports 14, 1181–1194, February 9, 2016 ª2016 The Authors 1185
Figure 4. Differential Requirement of Potential TFs for the ME and NE Fate Choices
(A and B) Scatterplot for T with Nac1 (A) and Oct4 (B) in cells with siRNA-mediated downregulation of Nac1 and Oct4, respectively, during ME differentiation
is shown.
(C and D) Scatterplot for Sox1-GFP with Tcf3 (C) and Sox2 (D) in cells with siRNA-mediated downregulation of Tcf3 and Sox2, respectively, during NE differ-
entiation is shown.
(E–H) Rescue of Nac1 (E) and Oct4 (F) duringME differentiation and Sox2 (G) and Tcf3 (H) during NE differentiation, following their respective siRNA transfections.
A 25-nM pool of siRNAs was used to downregulate Nac1, Oct4, Tcf3, and Sox2 during the indicated condition. Plasmid bearing the individual TF was co-
transfected with the siRNA for the rescue experiments in (E)–(H). Cells were transfected 12 hr prior to the addition of differentiation signal. Cells were fixed,
stained, and measurements were done at 72 hr of differentiation. Normalization was performed as in Figure 3 but using the maximum levels from mock-
transfected cells using scrambled siRNA alone (for A–D) or with an empty plasmid (for E–H) under the same experimental conditions.
See also Figure S5.these distinct quantitative patterns suggested a requirement of
Nac1 and Oct4 for the ME choice and Sox2 and Tcf3 for the
NE choice.
To confirm this, we utilized small interfering RNA (siRNA)-
mediated perturbation to modulate the protein levels during
differentiation. We first tested the siRNA for efficiency in down-
regulating the specific TF and effects on ESC survival. While a
scrambled siRNA pool was used as a negative control, pools
consisting of siRNAs against four sites of each target were
used to downregulate the TFs (Supplemental Experimental Pro-
cedures). Quantitative immunofluorescence of the target pro-
teins at 72 hr after siRNA transfection showed a significant
reduction in their expression, while ES colonies were still largely
intact (Figures S5A–S5G). Mock transfections with the scram-
bled siRNA pool (negative control) did not alter the normal TF
levels in ESCs (Figure S5G). However, after 6 days of transfec-
tion, a varying degree of effects was observed on ES colony
survival (Figure S5H). Consistent with their central role, we
found that Nac1, Oct4, Sox2, and Nanog downregulation
reduced ES survival by up to 80%. In contrast, Tcf3 and Klf4
had lesser effects, also consistent with their known functions.
While Klf4 is redundant for the ES state (Jiang et al., 2008),
Tcf3 downregulation is known to stabilize the ES state (Pereira
et al., 2006; Wray et al., 2011). Furthermore, mock transfection
of ESCs with scrambled siRNA did not induce ME or NE fates1186 Cell Reports 14, 1181–1194, February 9, 2016 ª2016 The Authoat 72 hr after transfection, thus ruling out the differentiation ar-
tifacts from transfection reagents alone (Figure S5I). Similarly
the transfection reagents did not alter the ESCs’ ability to differ-
entiate into either the ME or NE cell fates (Figures S5G, S5J,
and S5K).
We then used the siRNAs to downregulate Nac1 and Oct4
levels duringME differentiation and Sox2 and Tcf3 during NE dif-
ferentiation. The resulting single-cell protein levels, at 72 hr of dif-
ferentiation, were normalized as described above but with
maximal levels taken frommock-transfected cells (negative con-
trol). Forcing Nac1 and Oct4 to relatively low levels compro-
mised the ME choice (Figures 4A and 4B), more prominently
with Nac1 perturbation. The NE choice, on the other hand, was
equally compromised on reducing either Tcf3 or Sox2 level (Fig-
ures 4C and 4D). Ectopic overexpression of these TFs in cells
treated with siRNA largely rescued both the target TF levels as
well as the respective cell fate marker levels (Figures 4E–4H).
Although acute knockdown of these genes would cause defects
in ESCmaintenance (Figure S5H), theseME andNE lineage-spe-
cific phenotypes at 72 hr suggest that the general ESC differen-
tiation is not compromised under our conditions. In addition to
the specificity of siRNA pools used, the above results also
confirm the important role of some of the pluripotency TFs in pro-
moting differentiation: ME by Nac1 and Oct4 and NE by Sox2
and Tcf3.rs
Figure 5. Nac1 Coordinates the ME Fate
Selection through Oct4 Activation and Inhi-
bition of Sox2 and Tcf3
(A–D) Scatterplots for Nac1 with Oct4 (A), Sox2 (B),
and Tcf3 (C), and Oct4 with Sox2 (D) in cells with
siRNA-mediated downregulation of Nac1 and
Oct4, respectively, during ME differentiation.
siRNA transfection, differentiation, and normaliza-
tion were performed as in Figure 4. Dashed lines
indicate the expected maximum for a given TF in
mock-transfected cells under the ME condition.
(E) Schematic of the mathematical model based on
experimental data for ESC differentiation into the
ME and NE fates. Arrows indicate activation; blunt
ends indicate inhibition. Regulations that are
shown in red favorME fate choice and those shown
in blue favor NE fate choice. While T (ME fate
marker) expression was defined by Nac1 and Oct4
levels, Sox1 (NE fate marker) expression was
defined by Tcf3 and Sox2 levels (gray arrows).
(F) The model simulation results, with chosen
parameter values, on varying initial concentrations
for each TF and their resulting steady-state levels
for ME (red trajectories) and NE (blue trajectories)
differentiations. Results are projected as pairwise
combinations among Nac1, Oct4, Sox2, and Tcf3.
See also Figure S6 and the Supplemental Experi-
mental Procedures.Nac1 Activates Oct4 and Inhibits Tcf3 and Sox2 to Favor
the ME Fate
The repression of Nac1 andOct4 inNE cells and their presence in
ME cells indicated that theymight oppose the NE choice (Figures
3A–3D). Similarly, the repression of Sox2 andTcf3 inMEcells and
their presence in NE cells indicated that they might oppose the
ME choice (Figures 3E–3H). To gain further insights into the
possible mechanisms that may explain the distinct quantitative
patterns observed, we asked whether the regulations among
these TFs were different in ME and NE cells. We hypothesized
that in order to promote ME, Nac1 and Oct4 might repress NE
by inhibiting Sox2 and Tcf3, and vice versa. To understand these,
we systematically tested for the causal relationships among
Nac1, Oct4, Sox2, and Tcf3 during both the ME and NE differen-
tiation conditions, using specific siRNA perturbations.
We examined the impact of downregulating Nac1 or Oct4
during ME differentiation and Tcf3 or Sox2 during NE differen-Cell Reports 14, 1181–1194,tiation on changes in the levels of all four
identified factors, Nac1, Oct4, Sox2, and
Tcf3, as well as Nanog (Figures 5A–5D
and S6A–S6Q). Nac1 downregulation
during ME differentiation resulted in the
decrease of Oct4 level but an increase
in both the Sox2 and Tcf3 levels (Figures
5A–5C and S6Q). Similarly, downregula-
tion of Oct4 during ME differentiation re-
sulted in an increased Sox2 level (Figures
5D and S6Q) but had no effect on Nac1
and Tcf3 levels (Figures S6A and S6B).
These results indicated that, during MEchoice, Nac1 favors Oct4 expression and inhibits both Tcf3
and Sox2 and that Oct4 inhibits Sox2. By inhibiting the NE-pro-
moting TFs, both of these Nac1- and Oct4-mediated actions
favor the ME choice, and Nac1 in particular may play a central
role. In agreement with this, Nac1 downregulation resulted in
a prominent reduction of the ME fate (Figures S6M, S6N,
and S6Q).
In analyzing the NE fate, whereas Tcf3 and Sox2 downregula-
tion equally reduced the NE fate (Figures S6O and S6P), we
found no evidence that either Tcf3 or Sox2 inhibits either Nac1
or Oct4 (Figures S6E, S6F, S6I, and S6J). It is known that Tcf3 in-
hibits Oct4 and Nanog under pluripotency condition (Cole et al.,
2008; Pereira et al., 2006), but this may not continue in the NE
condition. However, both Nac1 and Oct4 are downregulated in
NE (Figures 3B and 3D), suggesting their indirect regulation,
either through retinoic acid signaling itself or other factors, rather
than one of the specific factors considered here. Similarly, a roleFebruary 9, 2016 ª2016 The Authors 1187
Figure 6. Nac1 Regulates the Extent of NE Choice and Suppresses It in Naive ESCs through Tcf3 Inhibition
(A and B) Themodel predictions for changes in Nac1, Tcf3, Sox2, and Oct4 levels on partial knockdown (KD) of Nac1 (A), and changes in theME (T) and NE (Sox1)
fate choices (B) upon partial knockdown of indicated protein, during the ME (red) and NE (blue) conditions, are shown.
(C–G) Nac1 downregulation-mediated changes in Tcf3, and Sox1-GFP levels during NE differentiation (C and D), under ES condition (E and F), and T and Sox1-
GFP levels under ES condition (G). Images show the overlay of Nac1 and Sox1-GFP images at the indicated condition.
(legend continued on next page)
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for the ME differentiation signals to inhibit Tcf3 was observed
(Figure 3G).
Downregulation of Nac1 and Oct4 under ME differentiation
and Sox2 during NE differentiation led to an enhanced reduc-
tion in undifferentiated ESCs (as measured by Nanog levels)
(Figures S6C, S6D, and S6H). Similarly, while Oct4 and Nac1
were limited from their high range (0.7–1) of expression under
ME (Figures 5A and S6A), they were restricted to the low range
(0–0.3) in cells with downregulated Sox2 under NE condition
(Figures S6E and S6F). On the other hand, Tcf3 downregulation
had no effects on Oct4, Nac1, Sox2, and Nanog levels (Figures
S6I–S6L). These results are consistent with the Nac1-, Oct4-,
and Sox2-mediated activation of Nanog to maintain pluripo-
tency (Figure S1A; Kim et al., 2008), and they further suggest
that these positive regulations are lost in ME- and NE-positive
cells (Figures S3J and S3K).
Nac1Modulates the Extent of NE Fate Selection through
Tcf3 Inhibition
Together, the above data suggested that the self-reinforcing reg-
ulations among a subset of TFs—Nac1, Oct4, Tcf3, and Sox2—
in ESCs are modified so as to favor the ME choice over the NE
choice. To reveal further functional outcomes that might be con-
cealed in our data, we constructed a mathematical model using
parsimonious assumptions to describe how the levels of Nac1,
Oct4, Sox2, and Tcf3 adjust to each other during either the ME
or NE differentiation (Figure 5E; Supplemental Experimental Pro-
cedures). The model was formulated to regulate ME choice
through repression of Tcf3 by Nac1 and of Sox2 by both Nac1
and Oct4, or NE choice through repression of Nac1 and Oct4,
mediated by either the NE differentiation signal itself or by
some as-yet unknown factors. The model was set up to exhibit
a single steady state for each differentiation regime (Figure S6R),
thereby reflecting the mutually exclusive choice between ME
and NE fates (Figures 1B and 1C). The model’s parameter values
were chosen manually to be consistent with our experimental
findings, so that the eventual steady-state levels of Nac1,
Oct4, Sox2, and Tcf3 fell within the ranges for cells expressing
high levels of the respective ME or NE fate marker. We also per-
formed parameter sensitivity analysis by varying each of the
model parameters by ±25% and found that the model is robust
to changes in parameter values (data not shown). Of the various
TF concentrations and their combinations tested, only high
levels of Nac1 and Oct4 favored the ME fate, and high levels of
Tcf3 and Sox2 favored the NE fate (Figure 5F).
Next, we utilized this simple model to predict the effects of se-
lective perturbation of Nac1, Oct4, Sox2, and Tcf3 on both the TF
levels and the fate selection. For the most part, simulated partial
knockdown of these factors recapitulated experimental results(H) Flow cytometry analysis for Sox1-GFP fluorescence in cells with (Nac1-si) and
Gray area indicates the cutoff used to measure percentage of positive (% Cells)
(I) Images showing the ectopic overexpression of Nac1-mCherry and the exten
overlays also are shown. Cells overexpressing Nac1-mCherry (Nac1-mC) are hig
(J and K) Scatterplots showing quantitative changes in Nac1-mC and Sox1-G
differentiation. Nac1 downregulation and normalizations were performed as in Figu
signal under the indicated condition in mock-transfected cells.
WT, wild-type; neg, negative control (scrambled siRNA); a.u., arbitrary units; f.u.,
Cell Rwith siRNA perturbations (Figures 6A, S6S, 5A–5D, and S6A–
S6P). However, the model also showed an increased level of
Tcf3 (Figure 6A) and an enhanced NE fate selection when
Nac1 was knocked down in NE condition (Figure 6B). To confirm
these unexpected predictions, we first downregulated Nac1 dur-
ing NE differentiation and consistently found twice the level of
Tcf3 (Figure 6C). To test the fate selection predictions, we down-
regulated each of the four TFs during both ME and NE differen-
tiations, andwemeasured the changes to both cell fates (Figures
S7A–S7H). The results reconfirmed the ME-promoting role of
Nac1 and Oct4 and the NE-promoting role of Sox2 and Tcf3.
In addition, enhanced Sox1-GFP signals upon Nac1 downregu-
lation during NE differentiation confirmed the model prediction
(Figures 6B, S7E, and 6D). To examine the role of Nac1 further,
we conducted similar experiments in ESCs in the absence of
any differentiation signals. Surprisingly, downregulating Nac1 re-
sulted in up to four times higher Tcf3 levels (Figure 6E). Nac1
downregulation alone was sufficient to trigger higher Sox1-
GFP expression and induce NE fate as the default choice in up
to 48% of naive ESCs (Figures 6F–6H). Furthermore, ESCs
with ectopic overexpression of Nac1 were blocked from NE
fate selection during the NE differentiation process (Figures 6I–
6K). These results suggested that Nac1 inhibits the NE-promot-
ing Tcf3 in ESCs as well as in ME and NE cells.
Both the model and the experimental results indicated that
downregulation of Tcf3 or Sox2 did not have any effects on the
ME choice (Figures S7C and S7D). Similarly, Oct4 downregula-
tion had no effect on the NE choice (Figure S7F). Taken together,
these results suggest an important central role for Nac1 in regu-
lating ESC differentiation into both the ME and NE cell fates.
While Nac1 in combination with Oct4 was required for the ME
choice, it strongly opposed NE and its downregulation was
required for the NE choice.
Nac1Differentially Binds to the DNARegulatory Regions
in ES, ME, and NE Cells
How does Nac1 coordinate other key pluripotency TFs to regu-
late ESC differentiation? Fate-specific modulation of gene
expression often results from direct binding of a TF to the regu-
latory regions of its target DNA (Davidson, 2006). In ESCs, plurip-
otency factors bind extensively to gene regions of each other to
regulate their expression (Cole et al., 2008; Kim et al., 2008).
Similarly, Oct4 is known to bind the regulatory region of Sox2
during ME differentiation (Thomson et al., 2011). To know if
Nac1 implemented similar mechanisms, we assessed it’s bind-
ing to genomic DNA in ES, ME, and NE cells. We performed
chromatin immunoprecipitation (ChIP) to isolate Nac1-bound
genomic DNA followed by next-generation sequencing (ChIP-
seq) to identify the specific gene regions and their enrichment.without (neg) Nac1 downregulation during pluripotency (ES) and NE conditions.
Sox1-GFP cells.
t of Sox1-GFP expression during NE differentiation. DAPI image and image
hlighted with a blue circle.
FP (J) and T and Sox1-GFP (K) levels during Nac1 overexpression and NE
res 4 and 5. Dashed lines indicate the expectedmaximumof Tcf3 or Sox1-GFP
fluorescence units. Scale bars represent 35 mm. See also Figures S6 and S7.
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Figure 7. Nac1 Binds Differentially to Regulatory Gene Regions in ES, ME, and NE Cells
(A) Percentage of Nac1-bound regions associated to annotated genes of the mouse genome (build mm9) in ESCs is shown.
(B) De novo motifs identified from the Nac1-bound target region sequences in ESCs. Three motifs covering the highest percentage of targets are shown.
(legend continued on next page)
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Because little is known about which target genes Nac1 regu-
lates, we first assessed such regulation in ESCs. The majority
of Nac1-bound regions were proximal to the transcription start
site (TSS) of associated genes (within 5 kb up or downstream
of the TSS), suggesting that it played a role in regulating the tran-
scription of its target genes (Figure 7A). The de novo Nac1-bind-
ing motifs identified were dominated by cytosine followed by
guanine content and were found in the majority of its target
sequences (Figure 7B). Nac1 motifs shared a similarity with TF
motifs involved in the regulation of ESCs, development, and tran-
scription (Klf4/5/7/1, Sp1, Smad3, etc.; Bouwman and Philipsen,
2002; Jiang et al., 2008; Mullen et al., 2011). In addition, we
observed significant enrichment of Nac1 binding at gene regions
associated with the regulation of gene transcription, translation,
ESC state, development, cell cycle, and signaling (Figure 7C;
Table S1).
In ESCs, ChIP-seq profiling of several pluripotency TFs has led
to the identification of Oct4- and Myc-centric modules (Chen
et al., 2008; Ng and Surani, 2011).While the Oct4-centric module
includes the core factors Oct4, Sox2, and Nanog, among others,
the Myc-centric module includes c-Myc, E2f1, and Zfx. To know
how Nac1 targets compare with these TFs, we analyzed its
target geneswith respect to theOct4 andMycmodule TF targets
(Figures 7D and 7E). Nac1 shared a few hundred targets with
each individual factor and all three factors of the Oct4 module
(433) (Figure 7D). Surprisingly, in comparison to the Oct4 mod-
ule, Nac1 shared approximately twice the number of targets
with all three factors of the Myc module (846) (Figure 7E). This
cross-analysis suggests that Nac1 is an important member of
the Mycmodule rather than the Oct4 module. Moreover, the ma-
jority of Nac1-binding regions are adjacent to the TSS (Figure 7A),
which is a characteristic feature of theMyc-centricmodule (Chen
et al., 2008; Ng and Surani, 2011). Together these cross-com-
parisons reveal important new insights into how Nac1 regulates
its target genes.
We then analyzed differential binding patterns of Nac1 in ES,
ME, and NE cells by ChIP-seq. ESCs were grown in culture
with LIF and BMP, and sorted T-GFP- and Sox1-GFP-positive
cells at 72 hr of differentiation were used as ME and NE cells,
respectively. Differential enrichment peaks were observed for
all four differentiation-promoting pluripotency factors (Fig-
ure 7F): Nac1 bound to regions of Oct4, Sox2, Tcf3, itself,
and Klf4 in ES and ME cells. In NE cells, on the other hand,
there were no peaks for Oct4 and the peaks at other TF regions
were weakly enriched. To verify these observations further and
to rule out the artifacts of sequencing, we performed qPCR for(C) Gene ontology and pathway terms enriched among the Nac1 target genes in
associated functional category (y axis).
(D and E) Comparison of Nac1 target genes with those of Oct4-centric module T
and Zfx (E), is shown.
(F) Genome tracks showingNac1-binding enrichment peaks detected at Oct4, Tcf
Gene locus, TSS, and the transcription orientation are indicated for each target.
(G) The regulations among the key TFs—Nac1, Oct4, Sox2, Tcf3, and Nanog—
quantitative pattern of Nac1 (red), Oct4 (orange), Tcf3 (blue), Sox2 (cyan), and Na
marker) levels are shown, beside the sub-network schematics, for ES, ME, and
bition. The balanced ES state (green cell) and its imbalance induced by indicated d
shown. Dashed line indicates the threshold signal used to regard a cell as T or Sox1
and relationships shown in light gray are under repression. Residual levels of Na
Cell Rthe sites detected in ChIP-seq by using ChIP samples from ES,
ME, and NE cells. We validated ChIP-qPCR by testing known
Nac1-binding regions for Oct4, Sox2, and Nanog in ESCs
(Kim et al., 2008) and multiple non-target regions from ChIP-
seq analysis. Although there was no enrichment of non-target
regions, known and new Nac1 binding regions were signifi-
cantly enriched (Figure S7I) in ESCs. Nac1 in ESCs bound to
its own regulatory regions and that of Tcf3 on a par with its
binding to Sox2 and Nanog regions (Figures 7F and S7I).
Nac1 bindings to these TFs were very similar in ME cells,
except for its slightly reduced binding to Oct4 and an increased
binding to Tcf3 (Figure S7I). A striking difference was observed,
however, in NE cells where Nac1 bound to none of the factors
significantly (above 3-fold), except for Tcf3 and Sox2.
In assessing Nac1 ChIP-seq data, we also observed differen-
tial enrichment of gene regions associated with various cell-
signaling pathways, mesoderm, neural tube patterning, and
mouse phenotypes (Figures S7J and S7K). Particularly the
ME-related signaling pathways, such as Wnt and Nodal, were
enriched in ME cells more than in NE cells (Gadue et al., 2006).
Verification of selected gene regions related tomesoderm devel-
opment (Smad2/3/4) and Wnt/Activin/Nodal signaling genes by
qPCR confirmed their high enrichment in ME cells, followed by
ESCs and lesser enrichment in NE cells (Figure S7I; Fei et al.,
2010; Gadue et al., 2006). Assessment of NE-promoting retinoic
acid-signaling targets (Rhinn and Dolle´, 2012) gave similar re-
sults: higher enrichment in ES and ME cells than in NE cells.
These results are consistent with the different Nac1 protein
levels; higher levels in ES and ME cells allowed maximal binding
to Nac1 targets, and its minimal level in NE cells resulted in the
loss of binding.
DISCUSSION
The data presented here reveal differentiation-promoting func-
tions of Nac1; confirm known roles of Oct4, Sox2, and Tcf3
(Atlasi et al., 2013; Kishi et al., 2000; Thomson et al., 2011);
and extend the repertoire of pluripotency TFs also utilized to
regulate early stages of ESC differentiation. Through integrative
and quantitative approaches, we have shown that these four plu-
ripotency factors regulate the ME versus NE choice of ESCs in
distinct ways. Nac1 in particular appears to play important roles
in fine-tuning the extent of ME and NE fate selection, as well as
the ESC state. Although we cannot rule out direct or indirect
participation of other TFs in regulating the ME and NE fates,
the TFs we have identified play significant roles in fate selection.ESCs. Data are shown graphically according to their p values (x axis) and the
Fs, Oct4, Sox2, and Nanog (D), and the Myc-centric module TFs, E2f1, c-Myc,
3, Sox2, Nac1, and Klf4 regions fromChIP-seq analysis in ES,ME, andNE cells.
See also Figure S7 and Experimental Procedures.
may robustly maintain the mutually balanced ESC state (above). Single-cell
nog (green) protein levels with respect to T (ME fate marker) and Sox1 (NE fate
NE cells. The ES sub-network is updated to include Nac1-mediated Tcf3 inhi-
ifferentiation signals to favor either theME (red cell) or the NE (blue cell) fate are
positive. Arrows indicate activation and blunt ends indicate inhibition. Proteins
c1 and its inhibition of Tcf3 in NE cells are shown in dark gray (below right).
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Although Nac1 had been shown to be an important TF for the
pluripotency (Kim et al., 2008; Wang et al., 2006), its functions in
ESCs as well as in other cell types remain surprisingly poorly un-
derstood. Nac1 is known to promote tumor proliferation and gain
of resistance to chemotherapy, including in cell types that origi-
nate from ME (Jinawath et al., 2009; Nakayama et al., 2006). It is
conceivable that Nac1 may play a role in the putative link be-
tween stem cells and cancer, with diverse functions in regulating
both development and disease.
Nac1-knockout mice exhibit a lower survival rate for embryos
or newborns, with surviving mice showing gross skeletal abnor-
malities (Yap et al., 2013). We observed significant enrichment of
Nac1 binding at regions associated with mouse phenotypes
such as abnormal rib development (Figure S7K), but the effect
of Nac1 knockout on early embryogenesis, especially in mice
that do not survive, has not been studied andwould complement
the results obtained here.
Similar to our results, certain TFs are reused during cell fate
specification from progenitors during hematopoietic develop-
ment (Mercer et al., 2011; Rothenberg et al., 2010). For instance,
during early hematopoiesis, PU.1 regulates myeloid, B cell, and
T cell fate choices from their common multipotent progenitor
cells (Mercer et al., 2011). PU.1 along with CEBPa also regulates
the macrophage versus neutrophil fate choice of granulocyte-
macrophage progenitor cells (Laslo et al., 2006). In these cases,
it is still not clear how the causal networks are reorganized from
the progenitor cells to differentiated cell types. However, taken
together with our findings in ESCs, these results suggest a
common strategy of reorganizing the progenitor cell networks
around a subset of shared factors. This may be an efficient
way to specify successive and alternative cell types during
development.
The data presented here suggest that the ES state may exist
as a composite balance among several of the differentiation-pro-
moting TFs (Figure 7G). Regulation of the quantitative pattern of
Nac1, Oct4, Sox2, Tcf3, and the central factor Nanog may
dictate the balance of the pluripotent ES state versus the ME
and NE states. In ESCs, Nac1, Oct4, Sox2, and Nanog spanned
all three possible ranges (low, medium, and high) of protein
levels, and they were expressed in strong correlation with each
other (Figures S3A–S3G). This suggests that, irrespective of
large cell-to-cell variations, the self-reinforcing regulations
among these TFs may promote a mutually balanced stable ES
state that resists differentiation. A strict stoichiometry of protein
levels among these TFs may reinforce the ES state, and
Nac1 might play a key role in it. The differentiation signals, how-
ever, effectively compromised the ES state by eliminating
Nanog-dependent positive regulations (Cole and Young, 2008;
MacArthur et al., 2012; Niwa, 2007; Silva and Smith, 2008).
They promoted a distinct fate choice by restraining the levels
of specific TFs within quantitative windows and repressing those
required for the alternative fate. However, the roles of extrinsic
signals for ME and NE lineage commitment are not completely
resolved in our data. While we show that the signals reconfigure
the TFs into forming new lineage-specific networks, it is not clear
how the reconfigured TFs integrate with signaling effectors, such
as Smad 2/3 and RARs. The connections between the transcrip-
tional and signaling networks are currently not well understood.1192 Cell Reports 14, 1181–1194, February 9, 2016 ª2016 The AuthoIn this study, we have investigated the differentiation process
through which pluripotent ESCs decide between the ME and NE
fates. We used computational analysis of population-averaged
data (Figure 2) to suggest which pluripotency TFs might play a
key role in these cell fate transitions, and thenwe exploited quan-
titative single-cell analysis and siRNA perturbation to identify the
causal interactions that underlie differentiation (Figures 3, 4,
and 5). This allowed us to make predictions at the molecular
level, such as the role of Nac1, which emerged as a central regu-
lator of differentiation. Our integrative methodology fully exploits
protein-level data, in contrast to previous work on pluripotency
network reconstruction in ESCs, which relies on a Boolean (on/
off) approximation (Dunn et al., 2014; Xu et al., 2014). We believe
our approach can be extended to analyze complex molecular
networks underlying cell fate choice in other developmental
and disease contexts, especially when augmented with new
methods for measuring multiple proteins in single cells (Bendall
et al., 2011).
EXPERIMENTAL PROCEDURES
ESC Culture and Differentiation
Mouse ESCs, R1 (E14-Tg2A), T-GFP, and Sox1-GFP, were cultured by stan-
dard methods in knockout DMEM supplemented with non-essential amino
acids, sodium pyruvate, L-Glutamine, b-mercaptoethanol, 15% fetal calf
serum (Hyclone), and LIF (1,000 m/ml, Millipore ESG1106). CHIR99021 (Stem-
gent 04-0004-02) and Activin-A (R&D Systems 338-AC-010) and retinoic acid
(Sigma-Aldrich) were used at the indicated concentrations for ME differentia-
tion and NE differentiation, respectively.
Quantitative Immunofluorescence
Immunofluorescence was performed as described previously (Mun˜oz Des-
calzo et al., 2012). The primary antibodies used are listed in the Supplemental
Experimental Procedures. A Nikon Ti inverted confocal microscope fitted with
perfect focus, 203 Plan-Apochromatic objective (numerical aperture [NA]
0.75) and Hamamatsu ORCA-AG cooled charge-coupled device (CCD) cam-
era were used for imaging.
Image Analysis and Normalization
Quantifications of fluorescence intensities were performed by semi-auto-
mated image analysis using Cell Profiler (Broad Institute; Carpenter et al.,
2006). Cells were segmented using the DAPI signals. Protein normalizations
were performed across multiple conditions using themaximum signal of a pro-
tein as described.
Perturbations
Target-specific ON-TARGET plus SMART siRNA pools, consisting of four con-
structs, from Dharmacon (Thermo Scientific) were used to downregulate TFs.
Cells were transfected with 25 nM of either scrambled siRNA (negative control)
or target-specific siRNA pools using DharmaFECT reagent 12 hr prior to the
addition of differentiation signals. Rescue of TFs during differentiation was
achieved through their ectopic overexpression from pmCherry-N1 vector
under CMV promoter.
ChIP
ChIP was performed using theMagna ChIP reagents (Upstate 17-409) accord-
ing to the manufacturer’s guidelines. ESCs grown in LIF and BMP4 medium
and sorted T-GFP- (ME) and Sox1-GFP- (NE) positive cells were used to
perform ChIP with 3 mg of Nac1 antibody (Abcam ab29047).
ChIP-Seq Analysis
Nac1-bound DNA was sequenced by next-generation sequencing using Illu-
mina HiSeq2500. Sequences were aligned to mm9mouse genome build using
Bowtie, peaks were called byMACS, and genes were assigned to peaks usingrs
GREAT andChIP-Enrich.While DREME and TOMTOMwere used formotif dis-
covery, gene ontology and pathway enrichment were performed using GREAT
and ChIP-Enrich.
ChIP-qPCR
The qPCR on ChIP DNA from ES, ME, and NE cells was performed in tripli-
cates on CFX96 RT-System (Bio-Rad) using the RT2 SYBR Green Fluor
(QIAGEN 330510). Ct values were first normalized to the input and then to
the normal mouse IgG (negative control) to calculate fold enrichment
(2DDCt). Relative fold enrichment was calculated over Igx1a. The primers
used for qPCR analysis are listed in the Supplemental Experimental
Procedures.
PCA and DBN
PCA was performed with custom code written in R by using singular value
decomposition of the centered matrix of median values. DBN on ME and NE
data was performed by implementing a custom modified version of the
EDISON package (Dondelinger et al., 2013) in R. Modifications introduced to
the EDISON package are described in the Supplemental Experimental Proce-
dures. The DBN code is available for download at https://github.com/
meghapadi/StemCellDBN.
Mathematical Modeling
Simulation and analysis of mathematical model were performed using open
source tools for Python (SciPy). Description of the model, its assumptions,
and parameters are provided in the Supplemental Experimental Procedures.
Full descriptions of the experimental and computational methods are pro-
vided in the Supplemental Experimental Procedures.
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